LianBio (LIANY)
OTCMKTS
· Delayed Price · Currency is USD
0.300
0.00 (-0.03%)
Nov 15, 2024, 1:56 PM EST
LianBio Market Cap
LianBio has a market cap or net worth of $32.44 million as of November 15, 2024. Its market cap has decreased by -78.22% in one year.
Market Cap
32.44M
Enterprise Value
-183.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 32.44M, a decrease of -97.75%. That is a compound annual growth rate of -71.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 15, 2024 | 32.44M | -93.28% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 19.62B |
| Telix Pharmaceuticals Limited | 4.99B |
| Elekta AB (publ) | 2.21B |
| Ryman Healthcare Limited | 1.94B |
| Verano Holdings Corp. | 691.10M |
| Vireo Growth Inc. | 102.39M |
| Medexus Pharmaceuticals Inc. | 34.65M |